March 30, 2015 - There are few global public health issues of greater importance than antimicrobial resistance in terms of impact on society. Many existing antimicrobials are becoming less effective and the development pipeline for new antibiotics is at an all-time low. Thus, change is needed to address antimicrobial resistance. This complex global public health challenge is tackled in a timely special focus issue of Future Microbiology, a peer-reviewed journal published by Future Medicine Ltd.
Modern medicine relies on the widespread availability of effective antimicrobials to prevent and treat infections in humans and animals. However, resistance to all antimicrobials is growing; bacterial resistance to antibiotics being of the greatest concern. Microbial evolution cannot be outpaced, therefore, the solution will involve global collaboration and a more intelligent use of antibiotics.
Future Microbiology's special focus issue brings together experts in the field to contribute on a broad range of topics to create a comprehensive update on antimicrobial resistance.
It includes a range of Reviews, Perspectives, Editorials and Primary Research papers that cover some of the ways in which we can address this problem. Coverage includes tools for screening and surveillance, to alternative therapeutic options.
"Antimicrobial resistance is a highly important public health concern, and its spread is complex and difficult to be completely prevented. Therefore, reinforcement of infection control tasks, along with in-time initiation of diagnosis and new therapeutic options are of utmost importance," said Natasha Leeson, Commissioning editor. "This Special Focus Issue reviews the existing evidence base on antimicrobial resistance, and highlights on-going and future research endeavors that may further strengthen the possibilities of containing antimicrobial resistance in the near future."
A full listing of articles included in the issue is available at: http://www.
Notes for editors
About Future Microbiology
The journal publishes original research, reviews and opinion pieces that cover all aspects of microbiological sciences, including virology, bacteriology, parasitology and mycology. Essential information is delivered in concise, at-a-glance article formats. Key advances in the field are reported and analyzed by international experts, providing an authoritative but accessible forum for this increasingly important and vast area of research.
Future Microbiology has an impact factor of 3.819, which ranks it 27th by impact factor out of 119 journals in the Microbiology category. The journal is indexed by Biobase, BIOSIS Previews, BIOSIS Reviews Reports and Meetings, Biotechnology Citation Index®, CAB abstracts, Chemical Abstracts, EMBASE/Excerpta Medica, Journal Citation Reports/Science Edition®, MEDLINE/Index Medicus, Science Citation Index Expanded™ (SciSearch®) and Scopus.
To find out more about Future Microbiology, please visit our website: http://www.
About Future Science Group
Founded in 2001, Future Science Group (FSG) is a progressive publisher focused on breakthrough medical, biotechnological and scientific research. FSG's portfolio includes two imprints, Future Science and Future Medicine. Both publish eBooks and journals. In addition to this core publishing business FSG develops specialist eCommunities. Key titles and sites include Bioanalysis Zone, Epigenomics, Nanomedicine and the award-winning Regenerative Medicine.
The aim of FSG is to service the advancement of clinical practice and drug research by enhancing the efficiency of communications among clinicians, researchers and decision-makers, and by providing innovative solutions to their information needs. This is achieved through a customer-centric approach, use of new technologies, products that deliver value-for-money and uncompromisingly high standards. http://www.